Corvus Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Corvus Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 66.7M shares, a 36.2% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 48M shares, a 3.16% increase from 2022.
  • Corvus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 46.6M shares, a 11.2% increase from 2021.
  • Corvus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 41.9M shares, a 42% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 66.7M +17.7M +36.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 59.7M +12.2M +25.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 49M +2.48M +5.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 48M +1.47M +3.16% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 49M +2.42M +5.19% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 47.5M +944K +2.03% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 46.6M +2.67K +0.01% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 46.6M +4.7M +11.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 46.6M +2.61M +5.93% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 46.6M +4.31M +10.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 46.6M +12M +34.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 41.9M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 43.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 42.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 34.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.